Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American pharmaceutical supply chain resiliency by filling and operationalizing the Strategic Active ...

Richmond-based Phlow Corp. has promoted Dan Hackman from chief business officer to president, the pharmaceutical manufacturing company announced Thursday. Hackman joined Phlow in 2020. He previously ...

Phlow is in a partnership with Utah-based pharmaceutical manufacturer Civica Inc., which plans to invest $124.5 million to establish its North American manufacturing headquarters operation in ...

Earlier this week, the U.S. government awarded a $354 million contract to a new public benefit company called Phlow to make generics that are in short supply during the pandemic. The move, which ...

RICHMOND, Va., May 19, 2020 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing ...

Richmond pharmaceutical company Phlow is looking to raise up to $50 million in outside funding. The round puts the company at a pre-money valuation of $230 million.

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.

Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American pharmaceutical supply chain resiliency by ...